Ad hoc: Biofrontera AG resolves on capital increase
(Thomson Reuters ONE) -
Biofrontera AG /
Keyword(s): Capital increase /
Ad hoc: Biofrontera AG resolves on capital increase
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Leverkusen, Germany, 23.04.2015 - The board of directors of Biofrontera AG
(Biofrontera) has resolved today, with the approval of the supervisory board, to
increase the registered capital of Biofrontera from currently EUR 22,196,570.00
by up to EUR 2,173,913.00 from authorized capital to up to EUR 24,370,483.00 by
issuing up to 2,173,913 new no-par registered shares ("New Shares"). The New
Shares are entitled to a participation in profits from 1 January 2014.
Shareholders will be offered the statutory subscription right in such a way that
Lang & Schwarz Broker GmbH, Düsseldorf, is admitted to subscribe and take over
the New Shares at an issue price of EUR 1.00, with the obligation to offer the
New Shares to the shareholders at a ratio of 10:1 against payment of EUR 2.30
per New Share ("Subscription Price") for subscription ("Subscription Offer").
The subscription period will run from 5 May 2015 to and including 19 May 2015.
If not all New Shares will be placed through the Subscription Offer,
shareholders who have already exercised their subscription rights may subscribe
additional shares by way of over-subscription. Any New Shares not acquired by
subscription or over-subscription will be offered to select investors in a
private placement. The offer period for the private placement shall end no later
than three trading days after the end of the subscription period.
Further details will be communicated in the Subscription Offer published in the
Federal Gazette on 27 April 2015.
Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611
Contact:
Biofrontera AG
Tel.: +49 (0214) 87 63 2 0, Fax.: +49 (0214) 87 63 290
E-mail: press(at)biofrontera.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biofrontera AG via GlobeNewswire
[HUG#1913994]
Unternehmensinformation / Kurzprofil:
Datum: 23.04.2015 - 14:23 Uhr
Sprache: Deutsch
News-ID 388103
Anzahl Zeichen: 2725
contact information:
Town:
Leverkusen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 135 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ad hoc: Biofrontera AG resolves on capital increase"
steht unter der journalistisch-redaktionellen Verantwortung von
Biofrontera AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
